Evogene
EVGN
EVGN
31 hedge funds and large institutions have $754K invested in Evogene in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
50% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 8
50% less call options, than puts
Call options by funds: $7K | Put options by funds: $14K
Holders
31
Holding in Top 10
–
Calls
$7K
Puts
$14K
Top Buyers
| 1 | +$21K | |
| 2 | +$14K | |
| 3 | +$10K | |
| 4 |
LW
Linscomb Wealth
Houston,
Texas
|
+$7K |
| 5 |
Morgan Stanley
New York
|
+$3.99K |
Top Sellers
| 1 | -$191K | |
| 2 | -$19.1K | |
| 3 | -$13K | |
| 4 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$12K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$8.52K |